Menu

Sana, CAMP4 ditch clinical-stage assets for more promising preclinical candidates

Article |

tealcodere9 7mo ago
Sana, CAMP4 ditch clinical-stage assets for more promising preclinical candidates

Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their pipelines on the most...

Comments (0)

Newest

No comments yet.